CTOs on the Move

Synovis Life Technologies

www.synovislife.com

 
Synovis Life Technologies Inc. is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Synovis Life Technologies Inc. is based in Saint Paul, MN. You can find more information on Synovis Life Technologies Inc. at www.synovislife.com
  • Number of Employees: 250-1000
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

EyeQue

We are dedicated to creating affordable, accessible, and accurate eye care solutions specifically for you and your family. Our founders bring patents from MIT and decades of eye care industry experience to create innovative eye care products that can be used in our every day lives. The traditional eye care system hasnt changed in decades, but our advanced optical technology combined with the modern capabilities of smartphones, have shaped a new avenue of health technology - at home vision testing.

Metrix Health Solutions

Metrix Health Solutions is a Andover, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

East Texas Council on Alcoholism

East Texas Council on Alcoholism is a Longview, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Medical Education Technologies Inc

Based in Sarasota, Fla., METI is the world's leading manufacturer of high- technology Human Patient Simulators. Its PediaSim(TM) is the first and only pediatric patient simulator in the world.

Foghorn Therapeutics

More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is pioneering a new, major class of drug targets to develop unprecedented therapies for cancer and other serious diseases. We have already validated multiple targets, are in the process of developing drug candidates in multiple types of cancer and are beginning to explore other diseases.